Catalyst Wire Dossier Catalyst Wire Dossier

House Dust Mite Sublingual Immunotherapy

Sublingual immunotherapy extract for dust mite · Stallergenes Greer
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for House Dust Mite Sublingual Immunotherapy, covering 2013-02-07 to 2025-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children [Phase 3]

See pricing